Pfizer’s Tanezumab REMS Cannot Make Benefit-Risk Positive, US FDA Panel Says

 
• By Sue Sutter
  
shutterstock 18043132 Hawaii - Oct. 24: A surfboard explodes beneath surfer Ezra Sitt's feet when he hits the lip of the wave Oct.24, 2007 at Rocky Point, Hawaii. This is a great example of a freak accident while surfing. M By Mana Photo
Tanezumab wiped out at its advisory committee meeting for use in osteoarthritis.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers